Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The BMJ logoLink to The BMJ
. 2001 Aug 4;323(7307):269–270. doi: 10.1136/bmj.323.7307.269

General practice workload implications of the national service framework for coronary heart disease: cross sectional survey

Julia Hippisley-Cox 1, Mike Pringle 1
PMCID: PMC35350  PMID: 11485958

Standards one to four of the national service framework for coronary heart disease require general practitioners in England to identify all patients with established coronary heart disease or stroke, record their coronary risk factors, and offer appropriate treatment and to identify and treat patients at high risk of developing coronary heart disease.1 We estimated the general practice workload involved in meeting these goals.

Participants, methods, and results

We invited 65 practices randomly selected from the 51 primary care groups in the Trent region to participate; 24 practices volunteered and 18 were recruited.2 Ethical approval was obtained. We identified two target groups of high risk patients aged 35-74: patients with a Read code for ischaemic heart disease or stroke or at least one prescription for a nitrate (group 1),3 and patients with a computer recorded Read code for diabetes or hypertension (excluding those in group 1) who would be at high risk of developing coronary heart disease (group 2).

During March and April 2000, we extracted details of ischaemic heart disease, comorbidity (diabetes, hypertension, and stroke), drug treatment, and other coronary risk factors (age, sex, family history of cardiovascular disease, most recent smoking status, body mass index, blood pressure, glycated haemoglobin, and fasting lipid concentrations) from the practice computers. Descriptive data were analysed in SPSS (version 8) and Stata (version 5.0).

Of the 98 137 registered patients, 10 325 (10.5%) patients aged 35-74 years had at least one of ischaemic heart disease, stroke, diabetes, and hypertension. Fasting serum cholesterol concentrations had been recorded for 2267/4455 (50.9%) patients in group 1 and 2478/5870 (42.2%) in group 2. Of these, 1527/2267 (67.4%) patients in group 1 and 1809/2478 (73.0%) in group 2 had fasting serum cholesterol concentrations >5 mmol/l, with 1448 (63.9%) and 400 (16.1%), respectively, taking lipid lowering agents. Of the 1076 patients with a recorded history of myocardial infarction, 692 (64.3%) had received a β blocker. Aspirin was being taken by 3213 (72.1%) patients in group 1 and 1326 (22.6%) in group 2. Reducing the blood pressure target from 160/90 to 140/85 mm Hg (the current recommended target4) increased the number of high risk patients needing improved control from 2702/10325 (26.2%) to 6375 (61.7%). Of the 1839 patients with diabetes, 1518 (82.5%) had a glycated haemoglobin value recorded on computer, and of these, 729 (48%) had a value ⩾7.5%, which indicated moderate to poor glucose control.

The number of patients who needed risk factors recorded on computer or further disease control measures was estimated on the basis of the proportion of patients in the whole study population (table). Practices varied 14-fold in recording risk factors on computer and fourfold in the need for further disease control measures. We estimate that in the average practice of 10 000 patients about 904 items will need recording and about 2221 disease control measures will be needed (see table).

Comment

The national service framework for coronary heart disease has profound implications for primary care. Changes in workload and funding vary substantially between general practices.

Our estimates are conservative for a number of reasons. Practices in the study had systems compatible with MIQUEST (a computer software programme for data extraction) and their data might be of better quality than those from an average practice. We looked at data recorded on computers; examination of manual records and other information systems might reveal higher numbers of cases and better standards of care. We did not include patients without heart disease, diabetes, or hypertension who may have an absolute cardiovascular risk of ⩾3% a year based on other risk factors. Our data included patients aged 35-74, but elderly patients have a higher cardiovascular risk and are more likely to gain from risk factor modification.5

Substantial variations in the recording of risk factors and the need for further disease control measures between practices were not explained by differences in the age-sex structure of the practice population. Some variation may be due to differences in how computer Read codes are used.

Table.

Age-sex standardised estimates of computer recording and disease control measures needed for patients aged 35-74 with established cardiovascular disease, diabetes or hypertension in a practice with a total list size of 10 000 patients. Values are means (ranges)

Crude percentage Age-sex standardised percentage Number of estimated age-sex standardised* items
Computer recording needed
Blood pressure recording (no value ever on computer) 0.87 (0.03-4.34) 0.92 (0.04-4.81) 42 (2-220)
Body mass index recording (no value ever on computer) 3.05 (0.30-9.97) 3.18 (0.30-9.70) 145 (14-444)
Smoking status recording (no value recorded) 1.94 (0.07-9.27)  2.05 (0.06-10.46) 94 (3-479)
Assessment (no family history details ever recorded)  7.18 (1.58-21.92)  7.51 (1.55-24.28)  344 (71-1111)
Fasting serum cholesterol recording  6.07 (1.98-11.27)  6.10 (2.14-11.28) 279 (98-516)
Total of items that needed recording   904 (188-2770)
Disease control measures needed
Advice for smoking cessation (last recording indicates current smoker) 4.28 (1.70-7.46) 4.30 (1.55-8.14) 197 (71-372)
Improved blood pressure control (last reading >160/90 mm Hg) 5.07 (1.50-9.96) 5.14 (1.61-9.90) 235 (74-453)
Improved blood pressure control (last reading >140/85 mm Hg) 11.79 (7.66-14.97) 12.04 (8.68-15.49)  551 (397-709)
Dietary advice (last recorded body mass index indicates obesity) 4.81 (1.78-8.80) 4.87 (1.65-8.02) 223 (75-367)
Improved control of hyperlipidaemia (latest fasting serum cholesterol >5 mmol/1)  4.67 (1.35-11.27)  4.70 (1.46-11.28) 215 (67-516)
Lipid lowering medication (latest fasting serum cholesterol >5 mmol/l but not taking lipid lowering medication)  6.07 (1.98-11.27)  6.10 (2.14-11.28) 279 (98-516)
Assessment for aspirin (established cardiovascular disease but not taking aspirin and no recorded contraindication) 10.35 (4.12-20.52) 10.68 (4.16-21.40)  489 (190-979)
Assessment for β blockers (history of myocardial infarction but not taking β blockers) 0.67 (0.08-1.42) 0.69 (0.08-1.48) 32 (4-68)
Total  2221 (976-3980)
*

Calculation assumes 45.75% of patients are aged 35-74 as in 1998 UK reference population (Office for National Statistics). Direct age-sex standardisation to 1998 UK census data was undertaken using Stata (version 5.0). 

Acknowledgments

We thank the 18 general practices that took part in the study.

Editorial by Toop and Richards

Footnotes

Contributors: JHC and MP initiated and designed the study. Nicola Crown, research assistant, and Andy Meal, lecturer in nursing, wrote the MIQUEST queries and organised the data collection. JHC designed and performed the data analysis. JHC and MP interpreted the results and drafted the paper. Carol Coupland, senior lecturer in statistics, advised on statistical revisions required by the editorial board. JHC is the guarantor of the paper.

Funding: Grant from Trent NHS Executive

Competing interests: None declared.

References

  • 1.Department of Health. National Service Framework for Coronary Artery Disease: Modern Standards and Service Models. London: HMSO; 2000. www.doh.gov.uk/pdfs/chdnsf.pdf (accessed 17 May 2001). [Google Scholar]
  • 2.Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ. 2001;322:832–834. doi: 10.1136/bmj.322.7290.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Campbell N, Thain J, Deans H, Ritchie L, Rawles J. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ. 1998;316:1430–1434. doi: 10.1136/bmj.316.7142.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ramsay L, Williams B, Johnstone G, MacGregor G, Poston L, Potter J, et al. British Hypertension Society guideline for hypertension management 1999: summary. BMJ. 1999;319:630–635. doi: 10.1136/bmj.319.7210.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Smith GD, Song F, Sheldon TA. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993;306:1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES